KORIN COLLINS: Open Payments
NPI 1730582743 · EMMETT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$141 in 7 payments from 5 companies in 2025. Trend: 2023 $104 · 2024 $342 · 2025 $141
Food & beverage: $141
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| ABBVIE INC. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: LEQVIO, UBRELVY, PREVNAR 20, NURTEC ODT, Rybelsus, TRELEGY ELLIPTA, Ozempic.
Industry payments across ID — which companies pay providers there.
